Cargando…
Diclazuril Protects against Maternal Gastrointestinal Syndrome and Congenital Toxoplasmosis
BACKGROUND: Toxoplasmosis is a common cause of foodborne, gastrointestinal and congenital syndrome with particularly severe or unknown health consequences. There is no safe and effective preventive or therapeutic modality against congenital toxoplasmosis or to eliminate the persistent chronic infect...
Autores principales: | Oz, Helieh S., Tobin, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025969/ https://www.ncbi.nlm.nih.gov/pubmed/24851194 http://dx.doi.org/10.4236/ijcm.2014.53017 |
Ejemplares similares
-
Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone
por: Oz, Helieh S.
Publicado: (2014) -
Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model
por: Oz, Helieh S., et al.
Publicado: (2012) -
Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon
por: Oz, Helieh S.
Publicado: (2014) -
Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery
por: Oz, Helieh S.
Publicado: (2014) -
Safety and efficacy of Coxiril(®) (diclazuril) for pheasants
por: Rychen, Guido, et al.
Publicado: (2018)